Biomarkers of ageing: Current state‐of‐art, challenges, and opportunities
MedComm – Future Medicine · 2023-06 · 2 (2)
DOI: 10.1002/mef2.50 ↗At a glance
Journal article in MedComm – Future Medicine, published online on 2023-06-18. Written by Ruiye Chen and 13 co-authors. Cited 60 times so far (Crossref); 335 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China.
Abstract (original language)
Given the unprecedented phenomenon of population ageing, studies have increasing captured the heterogeneity within the ageing process. In this context, the concept of “biological age” has been introduced as an integrated measure reflecting the individualized ageing pace. Identifying reliable and robust biomarkers of age is critical for the accurate risk stratification of individuals and exploration into antiageing interventions. Numerous potential biomarkers of ageing have been proposed, spanning from molecular changes and imaging characteristics to clinical phenotypes. In this review, we will start off with a discussion of the development of ageing biomarkers, then we will provide a comprehensive summary of currently identified ageing biomarkers in humans, discuss the rationale behind each biomarker and highlight their accuracy and clinical value with a contemporary perspective. Additionally, we will discuss the challenges, potential applications, and future opportunities in this field. While research on ageing biomarkers has led to significant progress and applications, further investigations are still necessary. We anticipate that future breakthroughs in this field will involve exploring potential mechanisms, developing biomarkers by combining various data sources or employing new technologies, and validating the clinical value of existing and emerging biomarkers through comprehensive collaboration and longitudinal studies.
Funding
- National Natural Science Foundation of China
Cite
APA
Chen, R., Wang, Y., Zhang, S., Bulloch, G., Zhang, J., Liao, H., Shang, X., Clark, M., Peng, Q., Ge, Z., Cheng, C., Gao, Y., He, M., & Zhu, Z. (2023). Biomarkers of ageing: Current state‐of‐art, challenges, and opportunities. MedComm – Future Medicine, 2(2). https://doi.org/10.1002/mef2.50
Vancouver
Chen R, Wang Y, Zhang S, Bulloch G, Zhang J, Liao H, et al. Biomarkers of ageing: Current state‐of‐art, challenges, and opportunities. MedComm – Future Medicine. 2023;2(2). doi:10.1002/mef2.50
BibTeX
@article{Chen2023,
author = {Chen, Ruiye and Wang, Yueye and Zhang, Shiran and Bulloch, Gabriella and Zhang, Junyao and Liao, Huan and Shang, Xianwen and Clark, Malcolm and Peng, Qingsheng and Ge, Zongyuan and Cheng, Ching‐Yu and Gao, Yuanxu and He, Mingguang and Zhu, Zhuoting},
title = {Biomarkers of ageing: Current state‐of‐art, challenges, and opportunities},
journal = {MedComm – Future Medicine},
year = {2023},
volume = {2},
number = {2},
doi = {10.1002/mef2.50}
}
EUVIMED